Sign Up to like & get
recommendations!
0
Published in 2025 at "Cancer"
DOI: 10.1002/cncr.35941
Abstract: KMT2A(11q23)‐rearranged acute myeloid leukemia (KMT2A‐r AML) represents a clinically aggressive subtype with heterogeneous outcomes. Current evidence remains inconclusive regarding the prognostic relevance of fusion partners in 11q23/KMT2A‐rearranged AML. The comprehensive mutational landscape and prognostic implications…
read more here.
Keywords:
acute myeloid;
kmt2a rearranged;
myeloid leukemia;
rearranged acute ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2025 at "Blood"
DOI: 10.1182/blood-2025-6866
Abstract: Objective:To investigate the efficacy and prognostic factors of single-center PDT-ALL-2016 regimen in the treatment of patients with KMT2A-rearranged acute lymphoblastic leukemia(KMT2A-r ALL). Methods:A total of 57 diagnosed patients with KMT2A-r ALL who received treatment in…
read more here.
Keywords:
pdt 2016;
year;
treatment;
2016 regimen ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2020 at "OncoTargets and therapy"
DOI: 10.2147/ott.s221643
Abstract: Background Mixed lineage leukemia (MLL) fusion protein alone exhibits poor histone lysine methyltransferase (HKMT) activity in catalyzing histone H3 Lys4 trimethylation (H3K4me3) in MLL-rearranged acute leukemia. Methods To explore the HKMT effect of another regulatory…
read more here.
Keywords:
leukemia;
rearranged acute;
expression;
acute leukemia ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2017 at "Haematologica"
DOI: 10.3324/haematol.2016.161000
Abstract: Ph-like acute lymphoblastic leukemia (Ph-like ALL) represents a high-risk subgroup of B-cell ALL.[1][1]–[7][2] By gene-expression, these patients have a profile similar to that of Ph+ ALL; however, they lack the BCR-ABL1 fusion. Patients with Ph-like…
read more here.
Keywords:
lymphoblastic leukemia;
rearranged acute;
crlf2 rearranged;
acute lymphoblastic ... See more keywords